CIK 0001388658 · Large accelerated filer
iRhythm Holdings, Inc.
Sign in to watch- Ticker
- IRTC
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 413421287
- Phone
- 415-632-5700
- Business address
- 699 8TH STREET, SUITE 600, San Francisco, CA, 94103
- Former names
- IRhythm Technologies, Inc., iRhythm Technologies, Inc., IRhythm Technologies Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $94,175
- in 1 filing
Net −$94,175. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-28 | Rosenbaum Marc Wade Chief Accounting Officer | Grant or award | +2 | $119.55 | $239 | 10,881 |
| 2025-11-28 | Shrishrimal Sumi EVP, Chief Risk Officer | Grant or award | +73 | $119.55 | $9K | 34,105 |
| 2025-11-10 | TALWALKAR ABHIJIT Y Director | Option exercise 10b5-1 | +5,312 | $10.71 | $57K | 25,611 |
| 2025-11-10 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −1,479 | $172.32 | $255K | 24,132 |
| 2025-11-10 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −222 | $172.83 | $38K | 23,910 |
| 2025-11-10 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −1,585 | $174.38 | $276K | 22,325 |
| 2025-11-10 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −1,300 | $174.94 | $227K | 21,025 |
| 2025-11-10 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −637 | $175.96 | $112K | 20,388 |
| 2025-11-10 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −89 | $177.85 | $16K | 20,299 |
| 2025-11-10 | TALWALKAR ABHIJIT Y Director | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,312 | $10.71 | $57K | 10,624 |
| 2025-11-03 | Blackford Quentin S. President and CEO | Sale | −14,059 | $182.94 | $2.6M | 164,979 |
| 2025-10-31 | Wilson Daniel G. Chief Financial Officer | Sale 10b5-1 | −8,000 | $207.44 | $1.7M | 26,470 |
| 2025-09-03 | Wilson Daniel G. Chief Financial Officer | Sale 10b5-1 | −5,000 | $175.00 | $875K | 34,470 |
| 2025-09-02 | Wilson Daniel G. Chief Financial Officer | Sale | −737 | $167.28 | $123K | 39,470 |
| 2025-08-22 | Shrishrimal Sumi EVP, Chief Risk Officer | Sale 10b5-1 | −653 | $167.12 | $109K | 34,032 |
| 2025-08-11 | Rosenbaum Marc Wade Chief Accounting Officer | Sale 10b5-1 | −226 | $158.93 | $36K | 10,879 |
| 2025-08-11 | TALWALKAR ABHIJIT Y Director | Option exercise 10b5-1 | +5,312 | $10.71 | $57K | 25,611 |
| 2025-08-11 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −3,183 | $157.57 | $502K | 22,428 |
| 2025-08-11 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 | −2,129 | $158.68 | $338K | 20,299 |
| 2025-08-11 | TALWALKAR ABHIJIT Y Director | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,312 | 15,936 |
Page 6 of 8 · 159 trades